These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1188 related articles for article (PubMed ID: 65222)
21. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037). Sonntag RW; Brunner KW; Batz K; Ryssel HJ Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125 [No Abstract] [Full Text] [Related]
22. Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study. Livingston RB; Helibrun L; Lehane D; Costanzi JJ; Bottomley R; Palmer RL; Stuckey WJ; Hoogstraten B Cancer Treat Rep; 1977 Dec; 61(9):1623-9. PubMed ID: 74281 [TBL] [Abstract][Full Text] [Related]
23. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Band PR; Canellos GP; Sears M; Israel L; Pocock SJ Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416 [No Abstract] [Full Text] [Related]
24. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors. Seiler RW; Vassella F; Markwalder H Surg Neurol; 1979 Mar; 11(3):237-42. PubMed ID: 473022 [TBL] [Abstract][Full Text] [Related]
25. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors. Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870 [TBL] [Abstract][Full Text] [Related]
26. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report. Takita H; Marabella PC; Edgerton F; Rizzo D Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692 [No Abstract] [Full Text] [Related]
27. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results. Rudolf Z; Plesnicar S Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959 [TBL] [Abstract][Full Text] [Related]
28. Modern problems of clinical chemotherapy of malignant tumours. Perevodchikova NI; Bychkov MB Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209 [TBL] [Abstract][Full Text] [Related]
29. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma. Shelley W; Quirt I; Bodurtha A; Iscoe N; Russell J; Paterson A; Young V Cancer Treat Rep; 1985 Sep; 69(9):941-4. PubMed ID: 2992784 [TBL] [Abstract][Full Text] [Related]
30. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer. Baker LH; Opipari MI; Wilson H; Bottomley R; Coltman CA Obstet Gynecol; 1978 Aug; 52(2):146-50. PubMed ID: 79991 [TBL] [Abstract][Full Text] [Related]
31. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma. Aranha GV; Grage TB Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082 [No Abstract] [Full Text] [Related]
32. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Einhorn LH; Burgess MA; Vallejos C; Bodey GP; Gutterman J; Mavligit G; Hersh EM; Luce JK; Frei E; Freireich EJ; Gottlieb JA Cancer Res; 1974 Aug; 34(8):1995-2004. PubMed ID: 4842252 [No Abstract] [Full Text] [Related]
34. Interleukin-2 plus chemotherapy for patients with metastatic melanoma. Paciucci PA; Ryder JS; Mandell JP; Morris JC; Holland JF Melanoma Res; 2000 Jun; 10(3):291-5. PubMed ID: 10890384 [TBL] [Abstract][Full Text] [Related]
35. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer. Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445 [TBL] [Abstract][Full Text] [Related]
36. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
37. Influence of therapy on the antioxidant status in patients with melanoma. Gadjeva V; Dimov A; Georgieva N J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784 [TBL] [Abstract][Full Text] [Related]
38. [Combined chemotherapy of disaeminated melanoma]. Moroz LV; Assekritova IV; Brazhnikova EI; Vaarik KhM; Voznyĭ EK Vestn Akad Med Nauk SSSR; 1978; (5):9-19. PubMed ID: 676469 [No Abstract] [Full Text] [Related]
39. [Results of a randomized polychemotherapy study in malignant melanoma]. Fiedler H; Hetschko I; Wohlrab W; Wozniak KD; Lübbe D; Taube KM Hautarzt; 1990 Jul; 41(7):369-74. PubMed ID: 1698185 [TBL] [Abstract][Full Text] [Related]
40. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]